Skip to content Skip to footer
Subscribe Now
Insights+: Key Takeaways of J.P. Morgan Healthcare Conference 2022 Based on Therapeutic Areas
INSIGHTS+
Insights+: Key Takeaways of J.P. Morgan Healthcare Conference 2022 Based on Therapeutic Areas
Shots:The 40th Annual J.P. Morgan Healthcare Conference took place virtually on Jan 10-13, 2022. The premier conference is the most extensive and most informative health care investment symposium in the Healthcare and pharma sector, which connects global leaders, emerging companies, innovative technology creators, and members of the investment communityConsidering the top biopharma companies…
January 19, 20220Comments
Viewpoints_Thomas C. Corbridge
VIEWPOINTS
PharmaShots Interview: GSK’s Thomas C. Corbridge Shares Insights on the New Survey Data for Severe Eosinophilic Asthma Patients
In an interview with PharmaShots, Thomas C. Corbridge, US Senior Medical Lead at GSK shares his views on the new survey and demonstrated dissatisfaction with the asthma treatment paradigmShots:The survey was commissioned by GSK and conducted by The Harris Poll in 100 patients aged ≥18yrs. showed that a majority of SEA patients and physicians are concerned about the current state…
January 18, 20220Comments
Viewpoints_Nikki Longwell
VIEWPOINTS
PharmaShots Interview: Janssen’s Nikki Longwell Shares Insights on the National Biologic Coordinators Day
In an interview with PharmaShots, Nikki Longwell, Sr. Director, Medical Science Liaisons, Immunology at Janssen shares her views on the launch of the National Biologic Coordinators Day supporting the needs of people living with autoimmune diseasesShots:The company has launched the first national awareness day “National Biologic Coordinators Day” on Nov 1 which is also known as a day…
January 17, 20220Comments
PharmaShots Interview Medicago’s Brian Ward Shares Insights on the Data of Plant-Based COVID-19 Vaccine
VIEWPOINTS
PharmaShots Interview: Medicago’s Brian Ward Shares Insights on the Data of Plant-Based COVID-19 Vaccine
In an interview with PharmaShots, Brian Ward, Medical Officer at Medicago shares his views on the P-III study of plant-based COVID-19 vaccine in combination with GSK’s pandemic adjuvant for the treatment of COVID-19 Shots:The company reported efficacy and safety results from the P-III study of Medicago’s plant-based COVID-19 vaccine candidate + GSK’s pandemic adjuvant in ~24,000 adults aged ≥18yrs. across Canada, US, UK,…
January 12, 20220Comments
PharmaShots Interview Insmed’s Martina Flammer Shares Insights on New Affordable Drugs for Rare Diseases
VIEWPOINTS
PharmaShots Interview: Insmed’s Martina Flammer Shares Insights on New Affordable Drugs for Rare Diseases
In an interview with PharmaShots, Martina Flammer, Chief Medical Officer at Insmed share her views on the R&D continuum to develop new drugs for rare diseases and also highlights its business pillarsShots:The idea of the continuum is that all department works together to develop the drugs which will be helpful not only for the company but for patients tooIn…
January 11, 20220Comments
Deal Maker of the Year 2021 (Part 01)
INSIGHTS+
Deal Maker of the Year 2021 (Part 01)
Shots:AstraZeneca and Roche were the top dealmakers completed 33 deals with multiple pharma and biotech companies and universities for a total deal value of $6.2B & $25.83BThe highest value deal was AstraZeneca’s partnership with Ionis for the development and commercialization of Eplontersen signed on Dec. 7, 2021.Merck and Pfizer are among the…
January 7, 20220Comments